172 related articles for article (PubMed ID: 9192800)
1. Enhanced expression of prostate-specific membrane antigen gene in prostate cancer as revealed by in situ hybridization.
Kawakami M; Nakayama J
Cancer Res; 1997 Jun; 57(12):2321-4. PubMed ID: 9192800
[TBL] [Abstract][Full Text] [Related]
2. Expression of prostate specific membrane antigen and three alternatively spliced variants of PSMA in prostate cancer patients.
Schmittgen TD; Teske S; Vessella RL; True LD; Zakrajsek BA
Int J Cancer; 2003 Nov; 107(2):323-9. PubMed ID: 12949815
[TBL] [Abstract][Full Text] [Related]
3. Prostate-specific membrane antigen is a hydrolase with substrate and pharmacologic characteristics of a neuropeptidase.
Carter RE; Feldman AR; Coyle JT
Proc Natl Acad Sci U S A; 1996 Jan; 93(2):749-53. PubMed ID: 8570628
[TBL] [Abstract][Full Text] [Related]
4. Alternatively spliced variants of prostate-specific membrane antigen RNA: ratio of expression as a potential measurement of progression.
Su SL; Huang IP; Fair WR; Powell CT; Heston WD
Cancer Res; 1995 Apr; 55(7):1441-3. PubMed ID: 7882349
[TBL] [Abstract][Full Text] [Related]
5. Expression of the prostate-specific membrane antigen.
Israeli RS; Powell CT; Corr JG; Fair WR; Heston WD
Cancer Res; 1994 Apr; 54(7):1807-11. PubMed ID: 7511053
[TBL] [Abstract][Full Text] [Related]
6. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
[TBL] [Abstract][Full Text] [Related]
7. Characterization and glutamyl preferring carboxypeptidase function of prostate specific membrane antigen: a novel folate hydrolase.
Heston WD
Urology; 1997 Mar; 49(3A Suppl):104-12. PubMed ID: 9123729
[TBL] [Abstract][Full Text] [Related]
8. Prostate-specific membrane antigen and its truncated form PSM'.
Mlcochová P; Barinka C; Tykvart J; Sácha P; Konvalinka J
Prostate; 2009 Apr; 69(5):471-9. PubMed ID: 19107881
[TBL] [Abstract][Full Text] [Related]
9. New alternatively spliced variant of prostate-specific membrane antigen PSM-E suppresses the proliferation, migration and invasiveness of prostate cancer cells.
Cao KY; Xu L; Zhang DM; Zhang XM; Zhang T; He X; Wang Z; Feng FS; Qiu SP; Shen GX
Int J Oncol; 2012 Jun; 40(6):1977-85. PubMed ID: 22322627
[TBL] [Abstract][Full Text] [Related]
10. In vitro modulation of tumor progression-associated properties of hormone refractory prostate carcinoma cell lines by cytokines.
Sokoloff MH; Tso CL; Kaboo R; Taneja S; Pang S; deKernion JB; Belldegrun AS
Cancer; 1996 May; 77(9):1862-72. PubMed ID: 8646686
[TBL] [Abstract][Full Text] [Related]
11. Identification, purification, and subcellular localization of prostate-specific membrane antigen PSM' protein in the LNCaP prostatic carcinoma cell line.
Grauer LS; Lawler KD; Marignac JL; Kumar A; Goel AS; Wolfert RL
Cancer Res; 1998 Nov; 58(21):4787-9. PubMed ID: 9809977
[TBL] [Abstract][Full Text] [Related]
12. Localization and physical mapping of the prostate-specific membrane antigen (PSM) gene to human chromosome 11.
Rinker-Schaeffer CW; Hawkins AL; Su SL; Israeli RS; Griffin CA; Isaacs JT; Heston WD
Genomics; 1995 Nov; 30(1):105-8. PubMed ID: 8595888
[TBL] [Abstract][Full Text] [Related]
13. Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.
Pinto JT; Suffoletto BP; Berzin TM; Qiao CH; Lin S; Tong WP; May F; Mukherjee B; Heston WD
Clin Cancer Res; 1996 Sep; 2(9):1445-51. PubMed ID: 9816319
[TBL] [Abstract][Full Text] [Related]
14. Detection of circulating prostate tumor cells: alternative spliced variant of PSM induced false-positive result.
Hisatomi H; Nagao K; Kawakita M; Matsuda T; Hirata H; Yamamoto S; Nakamoto T; Harasawa H; Kaneko N; Hikiji K; Tsukada Y
Int J Mol Med; 2002 Nov; 10(5):619-22. PubMed ID: 12373303
[TBL] [Abstract][Full Text] [Related]
15. Prostate-specific membrane antigen: evidence for the existence of a second related human gene.
Leek J; Lench N; Maraj B; Bailey A; Carr IM; Andersen S; Cross J; Whelan P; MacLennan KA; Meredith DM
Br J Cancer; 1995 Sep; 72(3):583-8. PubMed ID: 7669565
[TBL] [Abstract][Full Text] [Related]
16. Analysis of prostate-specific membrane antigen splice variants in LNCap cells.
Williams T; Kole R
Oligonucleotides; 2006; 16(2):186-95. PubMed ID: 16764542
[TBL] [Abstract][Full Text] [Related]
17. Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.
Zhang Y; Zippe CD; Van Lente F; Klein EA; Gupta MK
Clin Cancer Res; 1997 Jul; 3(7):1215-20. PubMed ID: 9815802
[TBL] [Abstract][Full Text] [Related]
18. Detection of circulating tumor cells in patients with prostate cancer using prostate specific membrane-derived primers in the polymerase chain reaction.
Noguchi M; Miyajima J; Itoh K; Noda S
Int J Urol; 1997 Jul; 4(4):374-9. PubMed ID: 9256327
[TBL] [Abstract][Full Text] [Related]
19. Expression of prostate-specific antigen and prostate-specific membrane antigen transcripts in blood cells: implications for the detection of hematogenous prostate cells and standardization.
Gala JL; Heusterspreute M; Loric S; Hanon F; Tombal B; Van Cangh P; De Nayer P; Philippe M
Clin Chem; 1998 Mar; 44(3):472-81. PubMed ID: 9510850
[TBL] [Abstract][Full Text] [Related]
20. Prostate-specific membrane antigen.
Fair WR; Israeli RS; Heston WD
Prostate; 1997 Jul; 32(2):140-8. PubMed ID: 9215402
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
